$ARX stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $13,641,873 of trading volume.
It has been the 555th most-searched ticker on Quiver Quantitative over the last day, out of 11,637 total tickers searched.
Here is what we see in our data on $ARX (you can track the company live on Quiver's $ARX stock page):
$ARX Insider Trading Activity
$ARX insiders have traded $ARX stock on the open market 7 times in the past 6 months. Of those trades, 6 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ARX stock by insiders over the last 6 months:
- JEFFREY L RADKE (Co-Founder, CEO) purchased 74,110 shares for an estimated $999,365
- JAY MICHAEL GREEN (Chief Financial Officer) sold 50,000 shares for an estimated $638,285
- FRANCIS JAMES ONEILL (Co-Founder, Chief U/W Officer) purchased 38,000 shares for an estimated $506,809
- CHRISTOPHER LEE-SMITH (Co-Founder, Head of Distrib.) purchased 14,700 shares for an estimated $197,240
- SAMUEL GAYNOR purchased 7,500 shares for an estimated $100,773
- MATTHEW DAVID STERNBERG (COO, Risk Exchange) purchased 5,700 shares for an estimated $74,695
- KAREN SUE MERIWETHER purchased 542 shares for an estimated $7,950
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$ARX Hedge Fund Activity
We have seen 55 institutional investors add shares of $ARX stock to their portfolio, and 57 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KEENAN CAPITAL, LLC added 3,139,980 shares (+inf%) to their portfolio in Q4 2025, for an estimated $51,338,673
- BLACKROCK, INC. removed 2,059,045 shares (-89.3%) from their portfolio in Q4 2025, for an estimated $33,665,385
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,984,001 shares (-84.2%) from their portfolio in Q4 2025, for an estimated $32,438,416
- AZORA CAPITAL LP added 1,811,976 shares (+288.9%) to their portfolio in Q4 2025, for an estimated $29,625,807
- FMR LLC added 1,229,490 shares (+220.1%) to their portfolio in Q4 2025, for an estimated $20,102,161
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,011,940 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $16,545,219
- BALYASNY ASSET MANAGEMENT L.P. added 714,811 shares (+35.4%) to their portfolio in Q4 2025, for an estimated $11,687,159
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$ARX Analyst Ratings
Wall Street analysts have issued reports on $ARX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 12/04/2025
- Piper Sandler issued a "Overweight" rating on 11/14/2025
- RBC Capital issued a "Outperform" rating on 10/31/2025
To track analyst ratings and price targets for $ARX, check out Quiver Quantitative's $ARX forecast page.
$ARX Price Targets
Multiple analysts have issued price targets for $ARX recently. We have seen 8 analysts offer price targets for $ARX in the last 6 months, with a median target of $17.5.
Here are some recent targets:
- Matthew Carletti from Citizens set a target price of $17.0 on 04/13/2026
- Bob Huang from Morgan Stanley set a target price of $15.0 on 04/06/2026
- Andrew Kligerman from TD Cowen set a target price of $30.0 on 03/26/2026
- Elyse Greenspan from Wells Fargo set a target price of $15.0 on 03/20/2026
- Paul Newsome from Piper Sandler set a target price of $13.0 on 02/23/2026
- Michael Harvey from RBC Capital set a target price of $28.0 on 02/09/2026
- Cameron Bean from Scotiabank set a target price of $30.0 on 11/07/2025
You can track data on $ARX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.